Key Record Dates
ClinicalTrials.gov Identifier: | NCT03289962 |
---|---|
Brief Title: | A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors |
First Submitted : | September 19, 2017 |
First Submitted that Met QC Criteria : | September 19, 2017 |
First Posted : | September 21, 2017 |
Last Update Submitted that Met QC Criteria : | April 25, 2024 |
Last Update Posted : | April 26, 2024 |